Based on surveys of 1,500 women diagnosed with
mostly early-stage breast cancers, researchers found that up to one
quarter were struggling financially as a result of their disease.
"Although we were able to control for factors such as overall
household income in this study, it is likely that other disparities
and challenges faced by minority populations persist in our society
even today, contributing to the differences observed," author Dr.
Reshma Jagsi told Reuters Health by email.
Jagsi worked on the study in the Department of Radiation Oncology at
the University of Michigan in Ann Arbor.
Between 2005 and 2007, she and her coauthors surveyed women
diagnosed with mostly early-stage breast cancers that had not spread
nine months after diagnosis and four years later. The women lived in
the Los Angeles and Detroit areas and about half had received
Of those women, 12 percent reported having medical debt at the
That group included nine percent of the white women participating in
the survey, compared to 10 percent of the Spanish-speaking Latinas,
17 percent of the English-speaking Latinas and 15 percent of the
black women, according to the results in the Journal of Clinical
These proportions persisted even when the researchers accounted for
income, education and employment.
About 35 percent of the women reported spending $2,000 or more
out-of-pocket on cancer treatments, and 17 percent spent more than
At the four-year mark, some survey questions assessed the level of
financial strain the women had been under for the past year.
Six percent of black women, compared to 3 percent of white women,
said they had taken less than the full amount of their prescribed
medications in the last year due to cost. Black and Latina women
were also more likely to have missed doctor appointments due to cost
than white women.
Black and Latina women were more likely to have gone without health
insurance or moved out of their houses due to cost since their
cancer diagnosis, although only five percent of women total had to
[to top of second column]
Two percent of white women reported having utilities turned off due
to unpaid bills, compared to 11 percent of black women.
"Overall, cancer is one of the most expensive diseases to treat in
the United States," Dr. S. Yousuf Zafar told Reuters Health by
Zafar, a medical oncologist at Duke Cancer Center in Durham,
North Carolina, was not involved in the new study.
"Compared to patients with chronic illnesses other than cancer,
patients with cancer are at risk for higher treatment-related
out-of-pocket expenses," he said.
Cancer patients face direct costs, like copayments for prescription
medications, visit copays, and coinsurance, and indirect costs, like
lost income from time off work, transportation for treatment, and
childcare, he said.
Minority populations might be especially at risk due to insufficient
employee health benefits, cultural barriers and poor health
literacy, he said, especially since Spanish-speaking Latinas were at
the greatest risk for declining financial status.
"Our findings suggest that racial and ethnic minority patients
appear to be more vulnerable, as are those who are too young to
qualify for Medicare, those who lack prescription drug coverage,
those who reduce their work hours after diagnosis, and those with
lower household income at the time of diagnosis," Jagsi said.
Women who receive chemotherapy or who have recurring breast cancers
may also be at higher risk for financial decline, she said.
Health care providers need to be sure to communicate with newly
diagnosed cancer patients about the financial implications of cancer
diagnosis and treatment decisions, she said.
"Specific provisions in the (Affordable Care Act), including annual
caps on out-of-pocket spending, will hopefully ease some of the
financial burden experienced by patients," Zafar said. "However, in
reality, we know very little about how those provisions will
actually translate into cost savings for patients."
Journal of Clinical Oncology, online March 24, 2014.
[© 2014 Thomson Reuters. All rights
Copyright 2014 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.